$1.21+0.08 (+7.08%)
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East.
Bon Natural Life Limited in the Basic Materials sector is trading at $1.21 with a market capitalization of $14M. The stock is currently near its 52-week low of $1.13, remaining 24.4% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q3 2025 | Q3 2024 | Q1 2024 | Q3 2023 | Q1 2023 |
|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | — | — | — | — | — |
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and th...
Volatility spiked in late March when the VIX reached 31.05 on March 27, 2026, before easing back to roughly 19.50, a level near the upper end of its typical range. The Federal Reserve has held its target rate at 3.50–3.75% since December 2025, and the 10‑year Treasury yield recently traded around 4.3%, within a 52‑week ... Treasury and Bond ETFs Are Back in Fashion: Here’s What to Own in April 2026
What are the early trends we should look for to identify a stock that could multiply in value over the long term...